{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:57:11Z","timestamp":1758121031826},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1007\/bf03345138","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T05:53:28Z","timestamp":1396072408000},"page":"117-122","source":"Crossref","is-referenced-by-count":7,"title":["GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome"],"prefix":"10.1007","volume":"26","author":[{"suffix":"Jr","given":"Francesco","family":"Orio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Palomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dentico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tauchmanov\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03345138_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N. Engl. J. Med. 1995, 333: 853\u2013861.","journal-title":"N. Engl. J. Med."},{"key":"BF03345138_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/BF03350782","volume":"21","author":"RB Barnes","year":"1998","unstructured":"Barnes R.B. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J. Endocrinol. Invest. 1998, 21: 567\u2013579.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345138_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJM199608293350909","volume":"335","author":"RD Utiger","year":"1996","unstructured":"Utiger R.D. Insulin and the polycystic ovary syndrome. N. Engl. J. Med. 1996, 335: 657\u2013658.","journal-title":"N. Engl. J. Med."},{"key":"BF03345138_CR4","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr. Rev. 1997, 18: 774\u2013800.","journal-title":"Endocr. Rev."},{"key":"BF03345138_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/BF03350779","volume":"21","author":"V Toscano","year":"1998","unstructured":"Toscano V. Polycystic ovary sindrome: What is it? Pathogenetic enigma and therapeutic dilemma. J. Endocrinol. Invest. 1998, 21: 546\u2013550.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345138_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/edrv-6-3-400","volume":"6","author":"EJ Adashi","year":"1985","unstructured":"Adashi E.J., Resnick C.E., D\u2019Ercole A.J., Svoboda M.E., Van Wyck J.J. Insulin-like growth factors as intraovarian regulators of granulosa cells growth and function. Endocr. Rev. 1985, 6: 400\u2013420.","journal-title":"Endocr. Rev."},{"key":"BF03345138_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0015-0282(16)55610-6","volume":"59","author":"E Katz","year":"1993","unstructured":"Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil. Steril. 1993, 59: 8\u201334.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/oxfordjournals.humrep.a137577","volume":"7","author":"R Homburg","year":"1992","unstructured":"Homburg R., Parente C., Lunenfeld B., Jacobs H.S. The role of insulin-like growth factor-I (IGF-I) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum. Reprod. 1992, 7: 1379\u20131383.","journal-title":"Hum. Reprod."},{"key":"BF03345138_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000182296","volume":"37","author":"GM Prelevic","year":"1992","unstructured":"Prelevic G.M., Wurzburger M.I., Balint-Peric L., Ginsburg J. Twenty-four hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries. Horm. Res. 1992, 37: 125\u2013131.","journal-title":"Horm. Res."},{"key":"BF03345138_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000181100","volume":"31","author":"ML Anapliotou","year":"1989","unstructured":"Anapliotou M.L., Syrigos K., Panayiotakopoulos G., Kalos A., Batrinos M.L. Paradoxical growth hormone response following thyroid stimulating hormone administration in the polycystic ovary syndrome. Horm. Res. 1989, 31: 119\u2013124.","journal-title":"Horm. Res."},{"key":"BF03345138_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1210\/jcem-71-4-958","volume":"71","author":"D Apter","year":"1990","unstructured":"Apter D., Butzow T.L.G.A., Yen S.S.C. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J. Clin. Endocrinol. Metab. 1990, 71: 958\u2013962.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000293322","volume":"29","author":"A Lanzone","year":"1990","unstructured":"Lanzone A., Fulghesu A.M., Pappalardo S. et al. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease: their relationships with hyperinsulinism and hyperandrogenism. Gynecol. Obstet. Invest. 1990, 29: 149\u2013153.","journal-title":"Gynecol. Obstet. Invest."},{"key":"BF03345138_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0015-0282(16)56878-2","volume":"62","author":"HH Hatasaka","year":"1994","unstructured":"Hatasaka H.H., Kazer R.R., Chatterton R.T., Unterman T.G., Glick R.P. The response of the growth hormone and insulin-like growth factor-I axis to medical castration in women with polycystic ovarian syndrome. Fertil. Steril. 1994, 62: 273\u2013278.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR14","first-page":"1432","volume":"74","author":"J Slowinska-Srzednicka","year":"1992","unstructured":"Slowinska-Srzednicka J., Zgliczynski W., Makowska A. et al. An abnormality of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity. J. Clin. Endocrinol. Metab. 1992, 74: 1432\u20131435.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2265.1995.tb02691.x","volume":"42","author":"GP Piaditis","year":"1995","unstructured":"Piaditis G.P., Kounadi T.G., Rangou D.B. et al. Dysfunction of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovarian syndrome. Clin. Endocrinol. 1995, 42: 635\u2013640.","journal-title":"Clin. Endocrinol."},{"key":"BF03345138_CR16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0015-0282(16)56397-3","volume":"60","author":"B Acar","year":"1993","unstructured":"Acar B., Kadanali S. Diminished growth responses to L-dopa in polycystic ovarian disease. Fertil. Steril. 1993, 60: 984\u2013987.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(16)56035-X","volume":"60","author":"EJ Lee","year":"1993","unstructured":"Lee E.J., Lee B.S., Lee H.C., Park K.H., Song C.H., Huh K.B. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil. Steril. 1993, 60: 53\u201357.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR18","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1210\/jcem-71-4-958","volume":"71","author":"RR Kazer","year":"1990","unstructured":"Kazer R.R., Unterman T.G., Glick R.P. An abnormality of the growth hormone\/insulin-like growth factor-I axis in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1990, 71: 958\u2013962.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/BF00931548","volume":"243","author":"W Urdl","year":"1988","unstructured":"Urdl W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet. 1988, 243: 13\u201336.","journal-title":"Arch. Gynecol. Obstet."},{"key":"BF03345138_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0015-0282(99)00634-2","volume":"73","author":"X-K Wu","year":"2000","unstructured":"Wu X.-K., Sallinen K., Zhou S.-Y., Su Y.-H., Pollanen P., Erkkola R. Androgen excess contributes to altered growth hormone\/insulin-like growth factor-I axis in nonobese women with polycystic ovary syndrome. Fertil. Steril. 2000, 73: 730\u2013734.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR21","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/oxfordjournals.humrep.a136150","volume":"100","author":"A Lanzone","year":"1995","unstructured":"Lanzone A., Villa P., Fulghesu A.M., Pavone V., Caruso A., Mancuso S. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary sindrome: relationship with obesity and hyperinsulinemia. Hum. Reprod. 1995, 100: 1653\u20131657.","journal-title":"Hum. Reprod."},{"key":"BF03345138_CR22","first-page":"2854","volume":"81","author":"AJ Morales","year":"1996","unstructured":"Morales A.J., Laughlin G.A., Butzow T., Maheshwari H., Baumann G., Yen S.S. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary sindrome: common and distinct features. J. Clin. Endocrinol. Metab. 1996, 81: 2854\u20132864.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0015-0282(98)00405-1","volume":"71","author":"P Villa","year":"1999","unstructured":"Villa P., Valle D., Mancini A. et al. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism. Fertil. Steril. 1999, 71: 115\u2013121.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR24","first-page":"E824","volume":"277","author":"JG Langendonk","year":"1999","unstructured":"Langendonk J.G., Meinders A.E., Burggraaf J. et al. Influence of obesity and body fat distribution on growth hormone kinetics in humans. Am. J. Physiol. 1999, 277: E824\u2013E829.","journal-title":"Am. J. Physiol."},{"key":"BF03345138_CR25","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.1210\/jcem.86.11.8061","volume":"86","author":"H Pijl","year":"2001","unstructured":"Pijl H., Langendonk J.G., Burggraaf J. et al. Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J. Clin. Endocrinol. Metab. 2001, 86: 5509\u20135515.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR26","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1056\/NEJM198411293112203","volume":"311","author":"T Williams","year":"1984","unstructured":"Williams T., Berelowitz M., Joffe S.N. et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N. Engl. J. Med. 1984, 311: 1403\u20131407.","journal-title":"N. Engl. J. Med."},{"key":"BF03345138_CR27","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/sj.ijo.0801289","volume":"24","author":"M Maccario","year":"2000","unstructured":"Maccario M., Grottoli S., Procopio M. et al. The GH\/IGF-I axis in obesity: influence of neuroendocrine and metabolic factors. Int. J. Obes. Relat. Metab. Disord. 2000, 24: S96\u2013S99.","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"BF03345138_CR28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/BF03350785","volume":"21","author":"JE Hall","year":"1998","unstructured":"Hall J.E. Taylor A.E. Hayes F.J. Crowley W.F. Jr. Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome. J. Endocrinol. Invest. 1998, 21: 602\u2013611.","journal-title":"J. Endocrinol. Invest."},{"issue":"Suppl.A","key":"BF03345138_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1096-6374(98)80010-5","volume":"8","author":"E Ghigo","year":"1998","unstructured":"Ghigo E., Amaretti G., Corneli G. et al. Diagnosis of GH deficiency in adults. Growth Horm. IGF Res. 1998, 8(Suppl.A): 55\u201358.","journal-title":"Growth Horm. IGF Res."},{"key":"BF03345138_CR30","first-page":"1615","volume":"83","author":"G Aimaretti","year":"1998","unstructured":"Aimaretti G., Corneli G., Razzore P. et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis for GH deficiency in adults. J. Clin. Endocrinol. Metab. 1998, 83: 1615\u20131618.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/ENDO:15:1:029","volume":"15","author":"E Ghigo","year":"2001","unstructured":"Ghigo E., Aimaretti G., Arvat E., Camanni F. Growth-hormone releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001, 15: 29\u201338.","journal-title":"Endocrine"},{"key":"BF03345138_CR32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D., Gallwey J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 1961, 21:1440\u20131447.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345138_CR33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0015-0282(01)01919-7","volume":"76","author":"AM Fulghesu","year":"2001","unstructured":"Fulghesu A.M., Ciampelli M., Belosi C., Apa R., Pavone V., Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary sindrome: the ovarian stroma\/total area ratio. Fertil. Steril. 2001, 76: 326\u2013331.","journal-title":"Fertil. Steril."},{"key":"BF03345138_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF03343585","volume":"22","author":"M Maccario","year":"1999","unstructured":"Maccario M., Gauna C., Procopio M. et al. Assessment of GH\/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test. J. Endocrinol. Invest. 1999, 22: 424\u2013429.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345138_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000049984","volume":"55","author":"F Orio Jr.","year":"2001","unstructured":"Orio F. Jr., Palomba S., Colao A. et al. Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Horm. Res. 2001, 55: 131\u2013136.","journal-title":"Horm. Res."},{"key":"BF03345138_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/meta.2002.31975","volume":"5","author":"JE Morley","year":"2002","unstructured":"Morley J.E., Patrick P., Perry III H.M. Evaluation of assays available to measure free testosterone. Metabolism 2002, 5: 554\u2013559.","journal-title":"Metabolism"},{"key":"BF03345138_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"BF03345138_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0960-0760(91)90179-9","volume":"40","author":"J Devesa","year":"1991","unstructured":"Devesa J., Lois N., Arce V., Diaz M.J., Lima L., Tresguerres J.A. The role of sexual steroids in the modulation of growth hormone (GH) secretion in humans. J. Steroid Biochem. Mol. Biol. 1991, 40: 165\u2013173.","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"BF03345138_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2265.1996.8380848.x","volume":"45","author":"D Micic","year":"1996","unstructured":"Micic D., Kendereski A., Popovic V. et al. Growth hormone response to GHRH, GHRH-6 and GHRH+GHRP-6 in patients with polycystic ovary syndrome. Clin. Endocrinol. 1996, 45: 385\u2013390.","journal-title":"Clin. Endocrinol."},{"key":"BF03345138_CR40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S1043-2760(98)00116-7","volume":"10","author":"FF Casanueva","year":"1999","unstructured":"Casanueva F.F., Dieguez C. Growth Hormone Secretagogues: physiological role and clinical utility. Trends Endocrinol. Metab. 1999, 10: 30\u201338.","journal-title":"Trends Endocrinol. Metab."},{"key":"BF03345138_CR41","first-page":"3030","volume":"84","author":"HJHMT Dessel Van","year":"1999","unstructured":"Van Dessel H.J.H.M.T., Lee P.D.K., Faessen G., Fauser B.C.J.M., Giudice L.C. Elevated serum levels of free insuline-like growth factor-I in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1999, 84: 3030\u20133035.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345138\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T21:21:03Z","timestamp":1581974463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["BF03345138"],"URL":"https:\/\/doi.org\/10.1007\/bf03345138","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}